|
PTTG1IP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.91050003279281E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.6348038174624E-11 |
| Normal-vs-Stage2 |
1.223650E-03 |
| Normal-vs-Stage3 |
2.18630000003994E-06 |
| Normal-vs-Stage4 |
3.603000E-03 |
| Stage1-vs-Stage2 |
2.297400E-01 |
| Stage1-vs-Stage3 |
2.419000E-01 |
| Stage1-vs-Stage4 |
4.436000E-03 |
| Stage2-vs-Stage3 |
7.499400E-01 |
| Stage2-vs-Stage4 |
3.513200E-01 |
| Stage3-vs-Stage4 |
1.376960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63840052636033E-10 |
| Normal-vs-AfricanAmerican |
1.286280E-02 |
| Normal-vs-Asian |
6.948400E-02 |
| Caucasian-vs-AfricanAmerican |
5.462700E-03 |
| Caucasian-vs-Asian |
6.566000E-01 |
| AfricanAmerican-vs-Asian |
5.963800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1262999977113E-08 |
| Normal-vs-Female |
1.52989999557818E-08 |
| Male-vs-Female |
3.231400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.502380E-02 |
| Normal-vs-Age(41-60Yrs) |
4.76490003009644E-09 |
| Normal-vs-Age(61-80Yrs) |
7.22899999860971E-08 |
| Normal-vs-Age(81-100Yrs) |
1.506320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.979800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.593600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.110800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.010200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.421800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.260600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.937400E-03 |
| Normal-vs-Grade 2 |
2.57993626462394E-12 |
| Normal-vs-Grade 3 |
1.02140000013407E-07 |
| Normal-vs-Grade 4 |
7.762500E-02 |
| Grade 1-vs-Grade 2 |
4.519600E-01 |
| Grade 1-vs-Grade 3 |
9.423600E-01 |
| Grade 1-vs-Grade 4 |
5.327600E-02 |
| Grade 2-vs-Grade 3 |
5.946400E-02 |
| Grade 2-vs-Grade 4 |
1.57249999688247E-08 |
| Grade 3-vs-Grade 4 |
2.416900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.53760337795461E-11 |
| Normal-vs-ccB subtype |
4.14699999995438E-06 |
| ccA subtype-vs-ccB subtype |
3.782300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.32500000550007E-08 |
| Normal-vs-N1 |
2.801000E-01 |
| N0-vs-N1 |
2.788600E-01 |
|
|
